Published in J Neuroimmunol on December 04, 2010
MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One (2012) 1.43
Suppressor of Cytokine Signaling (SOCS)1 Regulates Interleukin-4 (IL-4)-activated Insulin Receptor Substrate (IRS)-2 Tyrosine Phosphorylation in Monocytes and Macrophages via the Proteasome. J Biol Chem (2016) 1.41
Th17 cells in immunity and autoimmunity. Clin Dev Immunol (2013) 1.40
Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat Immunol (2012) 1.05
Therapeutic targeting of STAT pathways in CNS autoimmune diseases. JAKSTAT (2013) 0.90
Regulation of interferon gamma signaling by suppressors of cytokine signaling and regulatory T cells. Front Immunol (2013) 0.90
Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy. J Neuroimmunol (2012) 0.90
SOCS1 Mimetics and Antagonists: A Complementary Approach to Positive and Negative Regulation of Immune Function. Front Immunol (2015) 0.84
Inhibition of SOCS1-/- lethal autoinflammatory disease correlated to enhanced peripheral Foxp3+ regulatory T cell homeostasis. J Immunol (2011) 0.83
Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. J Interferon Cytokine Res (2014) 0.83
Isolation and th17 differentiation of naïve CD4 T lymphocytes. J Vis Exp (2013) 0.81
Short peptide type I interferon mimetics: therapeutics for experimental allergic encephalomyelitis, melanoma, and viral infections. J Interferon Cytokine Res (2014) 0.81
Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis. J Autoimmun (2015) 0.79
Regulation of Macrophage, Dendritic Cell, and Microglial Phenotype and Function by the SOCS Proteins. Front Immunol (2015) 0.78
MicroRNA-155 may be involved in the pathogenesis of atopic dermatitis by modulating the differentiation and function of T helper type 17 (Th17) cells. Clin Exp Immunol (2015) 0.78
Epigenetic enzymes are the therapeutic targets for CD4(+)CD25(+/high)Foxp3(+) regulatory T cells. Transl Res (2014) 0.78
Type I interferon mimetics bypass vaccinia virus decoy receptor virulence factor for protection of mice against lethal infection. Clin Vaccine Immunol (2014) 0.76
MicroRNA-155 deficiency promotes nephrin acetylation and attenuates renal damage in hyperglycemia-induced nephropathy. Inflammation (2015) 0.76
Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy. J Am Soc Nephrol (2016) 0.75
SOCS1 Mimetic Peptide Suppresses Chronic Intraocular Inflammatory Disease (Uveitis). Mediators Inflamm (2016) 0.75
SOCS1 is a negative regulator of metabolic reprogramming during sepsis. JCI Insight (2017) 0.75
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
IL-17 and Th17 Cells. Annu Rev Immunol (2009) 23.02
Structure and function of the blood-brain barrier. Neurobiol Dis (2009) 7.64
SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol (2007) 6.89
The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat Immunol (2009) 6.74
Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature (2001) 5.95
The immunopathology of multiple sclerosis: an overview. Brain Pathol (2007) 4.23
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol (2006) 3.94
The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J (1999) 3.77
The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol (2004) 3.76
Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann Neurol (2009) 2.87
Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol (2007) 2.85
SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol (2008) 2.72
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol (2009) 2.56
Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J Immunol (2008) 1.98
Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J Neuroimmune Pharmacol (2010) 1.91
Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med (2005) 1.88
From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev (2008) 1.65
Regulation of innate immunity by suppressor of cytokine signaling (SOCS) proteins. Immunobiology (2007) 1.38
Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. J Immunol (2008) 1.36
The SOCS box encodes a hierarchy of affinities for Cullin5: implications for ubiquitin ligase formation and cytokine signalling suppression. J Mol Biol (2009) 1.35
Interplay between pathogenic Th17 and regulatory T cells. Ann Rheum Dis (2007) 1.31
Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist. J Immunol (2007) 1.27
A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells. Oncogene (2005) 1.24
New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Lett (2005) 1.15
Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function. J Immunol (2004) 1.14
Therapeutic role of beta-interferons in multiple sclerosis. Pharmacol Ther (2005) 1.13
Mechanisms of immunopathology in murine models of central nervous system demyelinating disease. J Immunol (2006) 1.12
Encephalitogenic T cells that stably express both T-bet and ROR gamma t consistently produce IFNgamma but have a spectrum of IL-17 profiles. J Neuroimmunol (2009) 1.11
Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun Rev (2009) 1.11
The C-terminus of IFN gamma is sufficient for intracellular function. Biochem Biophys Res Commun (1994) 1.04
Models of autoimmune demyelination in the central nervous system: on the way to translational medicine. Exp Transl Stroke Med (2009) 1.03
Mal-function of TLRs by SOCS. Nat Immunol (2006) 0.99
IFN-gamma-derived lipopeptides: influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells. J Med Chem (1999) 0.91
Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling. Sci Signal (2009) 0.90
SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system. J Virol (2008) 0.89
Enhancement of antiproliferative activity of interferons by RNA interference-mediated silencing of SOCS gene expression in tumor cells. Cancer Sci (2008) 0.85
Knowns and unknowns in the future of multiple sclerosis treatment. J Neurol Sci (2009) 0.84
Extended anti-inflammatory action of a degradation-resistant mutant of cell-penetrating suppressor of cytokine signaling 3. J Biol Chem (2010) 0.83
Differential expression of SOCS1 in macrophages in relapsing-remitting and chronic EAE and its role in disease severity. Glia (2010) 0.82
Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat Immunol (2007) 2.85
Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol (2010) 2.00
Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells. J Immunol (2003) 1.80
Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS One (2010) 1.70
Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J (2007) 1.69
Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia (2008) 1.57
Iron efflux from astrocytes plays a role in remyelination. J Neurosci (2012) 1.56
Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J Biol Chem (2003) 1.54
Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci (2002) 1.52
Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol Rev (2006) 1.51
Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J Immunol (2005) 1.48
Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron (2004) 1.46
Comparison of nasopharyngeal and oropharyngeal swabs for the diagnosis of eight respiratory viruses by real-time reverse transcription-PCR assays. PLoS One (2011) 1.40
Lipocalin 2 plays an immunomodulatory role and has detrimental effects after spinal cord injury. J Neurosci (2011) 1.39
Corticospinal tract regeneration after spinal cord injury in receptor protein tyrosine phosphatase sigma deficient mice. Glia (2010) 1.36
Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain (2005) 1.36
Inhibition of type 1 diabetes correlated to a Lactobacillus johnsonii N6.2-mediated Th17 bias. J Immunol (2011) 1.34
Both the suppressor of cytokine signaling 1 (SOCS-1) kinase inhibitory region and SOCS-1 mimetic bind to JAK2 autophosphorylation site: implications for the development of a SOCS-1 antagonist. J Immunol (2007) 1.27
A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells. Oncogene (2005) 1.24
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study. Gynecol Oncol (2009) 1.23
A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron (2007) 1.22
A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses. BMC Med (2011) 1.21
Systemic injections of lipopolysaccharide accelerates myelin phagocytosis during Wallerian degeneration in the injured mouse spinal cord. Glia (2006) 1.20
Epidemiology, seasonality, and burden of influenza and influenza-like illness in urban and rural Kenya, 2007-2010. J Infect Dis (2012) 1.18
Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function. J Immunol (2004) 1.14
CD4+ CD25+ regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J Immunol (2004) 1.13
T cells contribute to lysophosphatidylcholine-induced macrophage activation and demyelination in the CNS. Glia (2007) 1.11
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis. Glia (2012) 1.11
Epidemiology of respiratory viral infections in two long-term refugee camps in Kenya, 2007-2010. BMC Infect Dis (2012) 1.09
Age-specific malaria seroprevalence rates: a cross-sectional analysis of malaria transmission in the Ouest and Sud-Est departments of Haiti. Malar J (2014) 1.09
Protecting motor neurons from toxic insult by antagonism of adenosine A2a and Trk receptors. J Neurosci (2006) 1.08
Tissue displacement and impact force are important contributors to outcome after spinal cord contusion injury. Exp Neurol (2005) 1.06
Ubc13 maintains the suppressive function of regulatory T cells and prevents their conversion into effector-like T cells. Nat Immunol (2012) 1.05
Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice. J Neurosci (2006) 1.03
The role of IFNgamma nuclear localization sequence in intracellular function. J Cell Sci (2003) 1.03
Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. Brain (2009) 1.03
Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci (2009) 1.03
A SLC4-like anion exchanger from renal tubules of the mosquito (Aedes aegypti): evidence for a novel role of stellate cells in diuretic fluid secretion. Am J Physiol Regul Integr Comp Physiol (2009) 1.02
HSV-1-induced SOCS-1 expression in keratinocytes: use of a SOCS-1 antagonist to block a novel mechanism of viral immune evasion. J Immunol (2009) 1.02
Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation. Am J Pathol (2010) 1.01
Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain (2008) 1.01
Genes involved in the balance between neuronal survival and death during inflammation. PLoS One (2007) 1.00
Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration. Mol Cell Neurosci (2003) 1.00
Differences in the phagocytic response of microglia and peripheral macrophages after spinal cord injury and its effects on cell death. J Neurosci (2014) 1.00
Regulation of postnatal forebrain amoeboid microglial cell proliferation and development by the transcription factor Runx1. J Neurosci (2012) 1.00
Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve. Exp Neurol (2009) 0.99
Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate. J Immunol (2002) 0.98
Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice. Glia (2010) 0.97
Beneficial effects of αB-crystallin in spinal cord contusion injury. J Neurosci (2012) 0.97
The single kinin receptor signals to separate and independent physiological pathways in Malpighian tubules of the yellow fever mosquito. Am J Physiol Regul Integr Comp Physiol (2010) 0.96
Fenretinide promotes functional recovery and tissue protection after spinal cord contusion injury in mice. J Neurosci (2010) 0.96
Plasma profiles in active systemic juvenile idiopathic arthritis: Biomarkers and biological implications. Proteomics (2010) 0.96
CD4+ T cells recognizing a single self-peptide expressed by APCs induce spontaneous autoimmune arthritis. J Immunol (2008) 0.96
Iron efflux from oligodendrocytes is differentially regulated in gray and white matter. J Neurosci (2011) 0.96
Enhancement of antiviral immunity by small molecule antagonist of suppressor of cytokine signaling. J Immunol (2010) 0.95
Controlling nuclear JAKs and STATs for specific gene activation by IFNγ. Biochem Biophys Res Commun (2011) 0.95
Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury. J Neurosci (2011) 0.95
Hepatitis E outbreak, Dadaab refugee camp, Kenya, 2012. Emerg Infect Dis (2013) 0.95
Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV. Bioorg Med Chem Lett (2003) 0.95
Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein. J Virol (2005) 0.94
Urine Peptidomic and Targeted Plasma Protein Analyses in the Diagnosis and Monitoring of Systemic Juvenile Idiopathic Arthritis. Clin Proteomics (2010) 0.93
CD4(+) CD25(+) regulatory T cell selection. Ann N Y Acad Sci (2004) 0.92
Spontaneous autoreactive memory B cell formation driven by a high frequency of autoreactive CD4+ T cells. J Immunol (2007) 0.92
Label-free optical detection of biomolecular translocation through nanopore arrays. ACS Nano (2014) 0.92
IFN mimetic as a therapeutic for lethal vaccinia virus infection: possible effects on innate and adaptive immune responses. J Immunol (2007) 0.92
Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth: a potential strategy for axonal regeneration. J Neurochem (2004) 0.90
Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-α and TGF-β1. Glia (2012) 0.90
Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy. J Neuroimmunol (2012) 0.90
Signaling to the apical membrane and to the paracellular pathway: changes in the cytosolic proteome of Aedes Malpighian tubules. J Exp Biol (2009) 0.90
Inactivation of myelin-associated glycoprotein enhances optic nerve regeneration. J Neurosci (2003) 0.90
SOCS-1 mimetics protect mice against lethal poxvirus infection: identification of a novel endogenous antiviral system. J Virol (2008) 0.89
Bi-directional control of motor neuron dendrite remodeling by the calcium permeability of AMPA receptors. Mol Cell Neurosci (2006) 0.89
Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord. Mol Cell Neurosci (2003) 0.89
Phospholipase A2 superfamily members play divergent roles after spinal cord injury. FASEB J (2011) 0.89
Mitogen-activated protein kinase-activated protein kinase 2 (MK2) contributes to secondary damage after spinal cord injury. J Neurosci (2010) 0.88
Superantigen enhancement of specific immunity: antibody production and signaling pathways. J Immunol (2002) 0.88
Beneficial effects of secretory leukocyte protease inhibitor after spinal cord injury. Brain (2010) 0.88
Signal transduction mechanism of a peptide mimetic of interferon-gamma. Biochemistry (2004) 0.88
IFN signaling: how a non-canonical model led to the development of IFN mimetics. Front Immunol (2013) 0.87
"Toxic memory" via chaperone modification is a potential mechanism for rapid Mallory-Denk body reinduction. Hepatology (2008) 0.87
Ceruloplasmin protects injured spinal cord from iron-mediated oxidative damage. J Neurosci (2008) 0.87
The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence. FEBS Lett (2004) 0.87
A potential biomarker in the cord blood of preterm infants who develop retinopathy of prematurity. Pediatr Res (2007) 0.86
Characterization of two beta-1,3-glucosyltransferases from Escherichia coli serotypes O56 and O152. J Bacteriol (2008) 0.86
Wetting and evaporation of binary mixture drops. J Phys Chem B (2008) 0.86
Graphene nanopore support system for simultaneous high-resolution AFM imaging and conductance measurements. ACS Appl Mater Interfaces (2014) 0.85
Placental ceruloplasmin homolog is regulated by iron and copper and is implicated in iron metabolism. Am J Physiol Cell Physiol (2002) 0.84
Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model. PLoS One (2012) 0.84
Inhibition of SOCS1-/- lethal autoinflammatory disease correlated to enhanced peripheral Foxp3+ regulatory T cell homeostasis. J Immunol (2011) 0.83
Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity. J Autoimmun (2008) 0.83